Wellness and longevity influencers are pushing a compound called NAD+. There's legitimate scientific interest in its potential, but researchers say the marketing claims are well ahead of the science. Reporter, Will Stone. Editor, Carmel Wroth. Radio piece and web.
Does NAD+ live up the hype?
Originally reported by NPR. Read the full story at the original source.
Related Articles
Ryan Jones: Unbreakable
Rugby legend Ryan Jones talks candidly about his early-onset dementia diagnosis.
Moral Maze
Close menu Use BBC.com or the new BBC App to listen to BBC podcasts, Radio 4 and the World Service outside the UK. Play...
A&E patients ending in 'corridors and cupboards'
A&E patients ending in 'corridors and cupboards'To play this video you need to enable JavaScript in your b...
An autism or ADHD diagnosis without access to treatment is a hollow outcome | Letter
Helen Macdonald responds to a report by the parliamentary and health service ombudsmanThe parliamentary and health servi...